{
    "Trade/Device Name(s)": [
        "i-STAT Alinity System with i-STAT Glucose test"
    ],
    "Submitter Information": "Abbott Point of Care Inc.",
    "510(k) Number": "K163271",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103195"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA"
    ],
    "Summary Letter Date": "March 13, 2017",
    "Summary Letter Received Date": "March 14, 2017",
    "Submission Date": "April 6, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "i-STAT Alinity Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric glucose oxidase assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Test",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for the i-STAT Alinity System with i-STAT Glucose test for quantitative measurement of glucose in arterial and venous whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in arterial and venous whole blood in point of care or clinical laboratory settings to aid in diagnosis, monitoring, and treatment of carbohydrate metabolism disorders, excluding neonates",
    "fda_folder": "Clinical Chemistry"
}